HKU Scholars Hub: Browsing DSpace

Browsing by Author Ma, BBY

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 12 of 12

	Title	Author(s)	Issue Date	Views
	The activity of mTOR inhibitor RAD001 (everolimus) in nasopharyngeal carcinoma and cisplatin-resistant cell lines Journal:Investigational New Drugs	Ma, BBY Lui, VWY Hui, EP Lau, CPY Ho, K Ng, MHL Cheng, SH Tsao, SW Chan, ATC	2010	155
	Activity of the MEK inhibitor selumetinib (AZD6244; ARRY-142886) in nasopharyngeal cancer cell lines Journal:Investigational New Drugs	Ma, BBY Lui, VWY Cheung, CS Lau, CPY Ho, K Hui, EP Tsui, SKW Ng, MH Cheng, SH Ng, PKS Tsao, SW Chan, ATC	2013	106
	Epigenetic identification of ADAMTS18 as a novel 16q23.1 tumor suppressor frequently silenced in esophageal, nasopharyngeal and multiple other carcinomas Journal:Oncogene	Jin, H Wang, X Ying, J Wong, AHY Li, H Lee, KY Srivastava, G Chan, ATC Yeo, W Ma, BBY Putti, TC Lung, ML Shen, ZY Xu, LY Langford, C Tao, Q	2007	113
	Erratum: Preclinical activity of gefitinib in non-keratinizing nasopharyngeal carcinoma cell lines and biomarkers of response (Investigational New Drugs DOI: 10.1007/s10637-009-9316-7) Journal:Investigational New Drugs	Ma, BBY Lui, VWY Poon, FF Wong, SCC To, KF Wong, E Chen, H Lo, KW Tao, Q Ng, MHL Cheng, SH Chan, ATC	2010	79
	Pharmacoproteomics study of cetuximab in nasopharyngeal carcinoma Journal:Journal of Proteome Research	Sung, FL Pang, RTK Ma, BBY Lee, MML Shuk, MC Poon, TCW Chan, ATC	2006	44
	Preclinical activity of gefitinib in non-keratinizing nasopharyngeal carcinoma cell lines and biomarkers of response Journal:Investigational New Drugs	Ma, BBY Lui, VWY Poon, FF Wong, SCC To, KF Wong, E Chen, H Lo, KW Tao, Q Chan, ATC	2010	98
	Preclinical evaluation of combined TKI-258 and RAD001 in hepatocellular carcinoma Journal:Cancer Chemotherapy and Pharmacology	Chan, SL Wong, C-H Lau, CPY Zhou, Q Hui, CWC Lui, VWY Ma, BBY Chan, ATC Yeo, W	2013	41
	Preclinical evaluation of sunitinib as single agent or in combination with chemotherapy in nasopharyngeal carcinoma Journal:Investigational New Drugs	Hui, EP Lui, VWY Wong, CSC Ma, BBY Lau, CPY Cheung, CSF Ho, K Cheng, S-H Ng, MHL Chan, ATC	2011	41
	Preclinical evaluation of the AKT inhibitor MK-2206 in nasopharyngeal carcinoma cell lines Journal:Investigational New Drugs	Ma, BBY Lui, VWY Hui, CWC Lau, CPY Wong, C-H Hui, EP Ng, MH Tsao, SW Li, Y Chan, ATC	2013	48
	Preclinical evaluation of the mTOR-PI3K inhibitor BEZ235 in nasopharyngeal cancer models Journal:Cancer Letters	Ma, BBY Lui, VWY Hui, CWC Lau, CPY Wong, CH Hui, EP Ng, MHL Cheng, SH Tsao, SW Tsang, C-M Cheung, CSF Ho, K Chan, ATC	2014	82
	STAT3 activation contributes directly to Epstein-Barr virus-mediated invasiveness of nasopharyngeal cancer cells in vitro Journal:International Journal of Cancer	Lui, VWY Wong, EYL Ho, Y Hong, B Wong, SCC Tao, Q Choi, GCG Au, TCC Ho, K Yau, DMS Ma, BBY Hui, EP Chan, ASK Tsang, CM Tsao, SW Grandis, JR Chan, ATC	2009	85
	The preclinical activity of the histone deacetylase inhibitor PXD101 (belinostat) in hepatocellular carcinoma cell lines Journal:Investigational New Drugs	Ma, BBY Sung, F Tao, Q Poon, FF Lui, VW Yeo, W Chan, SL Chan, ATC	2010	42

Showing results 1 to 12 of 12